StockTipsArenaBeta

BUY Glenmark Pharmaceuticals — Pankaj Randad

BUYGlenmark Pharmaceuticals
Glenmark Pharmaceuticals share price target & all analyst calls

byPankaj RandadHorizon: NA (inferred BTST)9 Jun 2026, 11:30 pm ISTvia CNBC Awaaz.

Entry₹2,283Stated
Target₹2,350
Total upside +2.93% (call closed)
Stop loss₹2,260-1.01% risk
Exit—No position was opened
ExpiredNA
Follow Pankaj Randad for new calls(20% target hit, 15 closed calls)Get alertsWatch GLENMARK for new buy/sell callsGet alertsSee 3 active BTST picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 11:54 pm IST
2 supporting0 opposing
Supports the BUY call (2)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·9 Jun · 2d ago

Glenmark Pharmaceuticals Inc., USA has launched Lacosamide Injection USP, 200 mg/ 20mL (10 mg/mL), Single-Dose Vials.

BSE · Company Update·5 Jun · 6d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Glenmark Pharmaceuticals

All analyst calls on Glenmark Pharmaceuticals

More from Pankaj Randad

Every call and its outcome